Unbiased Analysis of Today's Healthcare Issues
This is the title of my article at pharmaphorum. The precis of the article is below. The Institute for Clinical and Economic Review (ICER) measures the value of new drugs and health technologies, but faces a number of key challenges such as keeping their assessments up to date with new evidence, allowing for different perspectives…
My colleagues Jeroen Jansen, Devin Incerti along with Jeff Curtis think so. In JMCP they write: In the United States, there is an increased interest to understand the value of health technologies. Cost-effectiveness analysis is arguably the most appropriate framework to quantify value and to inform reimbursement decision making regarding medical interventions; however, a thorough…
QuantEcon is an interesting site from some high profile economists advocating for open-source tools for quantitative economic analysis. The organization describes itself on their website as follows: QuantEcon is a nonprofit organization dedicated to improving economic modeling by enhancing computational tools for economists. Our activities include developing and facilitating the development of open source software…
While many advancements have been made thus far in the progression toward value-based health care, there are persistent challenges in the measurement of value. In order to deliver value-based care, health care decision makers, eg, insurers and health system administrators, need value data at their fingertips—data that are relevant to their own context and reflect…